Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?
Magarian
G J
GJ
Department of Medicine, Oregon Health Sciences University, Portland.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001581:Benzothiadiazines; D003363:Cost Control; D004232:Diuretics; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics; D012110:Reserpine / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D012110:Reserpine